Detalhe da pesquisa
1.
An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
J Cutan Med Surg
; 27(6): 614-620, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942582
2.
The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.
J Cutan Med Surg
; 27(4): NP1-NP36, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37401812
3.
Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety.
J Cutan Med Surg
; 26(4): 404-413, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379011
4.
Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
J Cutan Med Surg
; 28(1): 79-81, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156654
5.
Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors.
J Am Acad Dermatol
; 88(4): 869-870, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228936
6.
Modes of Transmission and Clinical Manifestations of Monkeypox Virus.
J Cutan Med Surg
; 26(5): 534-535, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943038
7.
In Preparation for Biosimilar "Switch" Policy: How to Mitigate the Nocebo Effect.
J Cutan Med Surg
; 26(2): 203-205, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649465
8.
Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
SAGE Open Med Case Rep
; 11: 2050313X231180775, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37359284
9.
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.
Front Med (Lausanne)
; 9: 821871, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355606